Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030 | Convenience and At-Home Accessibility Afforded by Injectable Pharmaceuticals are Key Factors Driving Industry Demand, Says Emergen Research
Insmed to Showcase New Data Across Three Pillars at the American Thoracic Society 2022 International Conference
Cumberland County Man Pleads Guilty To Health Care Fraud, Money Laundering, And Theft Of Public Money
New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix’s RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency Department Is Published in Advances In Therapy
Federal Jury Convicts Baton Rouge Man of Fraud Scheme and Money Laundering Relating to Financial Aid Fraud
